When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Diabetic Kidney Disease?

Journal Title: Нирки - Year 2017, Vol 6, Issue 1

Abstract

International guidelines do not recommend angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) usage in the first stage of diabetic kidney disease. It shows the view, based on a small statistical sample, that olmesartan (or possibly other ACE inhibitors/ARBs) should be used to prevent the transition of the first stage of diabetic kidney disease to the second one in type 2 diabetes mellitus.

Authors and Affiliations

D. D. Ivanov

Keywords

Related Articles

Renal Artery Stenosis of the Transplanted Kidney

The article describes the results of observation of the patient with stenosis of the main artery of the transplanted kidney before and after balloon dilation of stenosis. The kidney was studied by Ultrasound, Doppler and...

Effectiveness of pantocrinum in the complex treatment of chronic kidney disease

The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological...

Renoprotective Effects of Low-protein Diet with the Use of Keto-analogues of Essential Amino Acids Using

The article discusses the role of low-protein diet and keto-analogues of essential amino acids in patients with impaired renal function. On the basis of results of the study on regularities of monocyte chemoattractant pr...

Thyroid dysfunction and kidney diseases

Thyroid hormones provide normal functioning of the kidneys, which in turn are not only an organ for the metabolism and excretion of thyroid hormones but also serve as targets for the action of certain thyroid hormones. H...

Violation of renal and peripheral hemodynamics in the development of cardiovascular disorders in children with chronic pyelonephritis

Background. Prompt detection of changes in the cardiovascular system in children with chronic pyelonephritis is important for slowing down the development of arterial hypertension and the progression of chronic kidney di...

Download PDF file
  • EP ID EP208749
  • DOI 10.22141/2307-1257.6.1.2017.93781
  • Views 103
  • Downloads 0

How To Cite

D. D. Ivanov (2017). When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Diabetic Kidney Disease?. Нирки, 6(1), 31-35. https://europub.co.uk/articles/-A-208749